Now Open: 2024 Echo Florida Registration

Registration is now open for the 12th Annual Echo Florida, which will take place October 12-14, 2024, at Disney’s Grand Floridian Resort & Spa in Lake Buena Vista, Florida. Register early and save up to $225!

This year, attendees will register for Echo Florida through ASE’s Learning Hub. There are three registration options:

NOTE: Remember to log in to the ASE Member Portal before accessing the Learning Hub to also receive your member registration discount.

This annual course offers a comprehensive review of cardiovascular ultrasound, and this year will also include a new interactive format with hands-on workshops. Attendees can earn up to 20.25 CME/MOC credits.

EchoGuide Surpasses 65,000 Downloads

Since its release 18 months ago, ASE’s FREE calculator and algorithm app EchoGuide has been downloaded more than 65,000 times!

Enjoying EchoGuide? Let us know by writing a review in the Apple or Android App stores. Potential users will benefit from reading about your favorite app features and how this resource helps you in your day-to-day practice.

If you haven’t already, Download EchoGuide for access to more than 50 easy-to-use calculators, algorithms, and charts based on key ASE guidelines. The app is available in the Apple and Google Play stores and on the web

IGE Registry Welcomes Four New Participating Institutions and BMS as a Sponsor

FOR IMMEDIATE RELEASE

Contact: Angie Porter
919-297-7152
APorter@ASEcho.org

ASE’s ImageGuideEcho Registry Welcomes Four New Participating Institutions and Bristol Myers Squibb as a Sponsor

(DURHAM, NC, May 14, 2024)—The American Society of Echocardiography (ASE) is pleased to announce the addition of four new participating institutions to its renowned ImageGuideEcho RegistryTM. Over the past year, ASE has seen significant growth in its Registry, with the inclusion of Allina Health, Children’s Mercy Kansas City, University of Pennsylvania, and Lee Health. These institutions join six previously enrolled institutions aiming to support the Registry’s ongoing efforts to assess specific quality metrics and patient outcomes to drive technology application and quality improvement within the field of echocardiography and patient care.

Allina Health, a leading healthcare system based in Minnesota, became a participating institution on August 25, 2023. Children’s Mercy Kansas City, the first pediatric medical center to enroll in the Registry, joined on December 11, 2023. The University of Pennsylvania, renowned for its exceptional medical education and research, became a participating institution on February 22, 2024. Lee Health, a leading healthcare system in Southwest Florida, joined the Registry on March 28, 2024.

“We are thrilled to have these new institutions as a part of the ImageGuideEcho Registry,” said Jordan Strom, MD, MSc, FASE, ASE ImageGuideEcho Registry Committee Chair. “ With the addition of these four institutions, the Registry now encompasses an even broader range of healthcare settings, enhancing its ability to capture a comprehensive snapshot of echocardiography practice in the United States. This expansion reflects the growing recognition of the Registry’s value in improving patient outcomes and promoting evidence-based practice.”

In addition to the new participating institutions, ASE is proud to welcome Bristol Myers Squibb as a Gold Sponsor. Bristol Myers Squibb’s support will enable the Registry to further its mission of promoting excellence in cardiovascular ultrasound and improving patient outcomes.

“At Bristol Myers Squibb, we are committed to transforming patients’ lives through science,” said Cecilia Marta, PhD, CMD, VP, Head of U.S. Medical Cardiovascular and Established Brands, Bristol Myers Squibb. “We are proud to support ASE’s ImageGuideEcho Registry, as it aligns with our desire to advance cardiovascular care and underscores our belief in the power of data-driven insights to drive meaningful change for patients.”

The Registry serves as a comprehensive resource for healthcare professionals, providing valuable data and insights to enhance the quality of echocardiography imaging. The addition of these four institutions and the support of Bristol Myers Squibb, helps bolster the continued growth and success of the ImageGuideEcho Registry.

“We are extremely grateful to Bristol Myers Squibb for their commitment that will help us further our mission of promoting excellence in cardiovascular ultrasound and improving patient outcomes,” said Dr. Strom. “I encourage other institutions and sponsors to join the Registry and contribute to the ongoing efforts to enhance the quality and safety of echocardiography. By participating in the Registry, institutions can gain access to valuable data-driven insights, identify areas for improvement, and benchmark their performance against national standards.”

About ImageGuideEchoTM Registry

ImageGuideEchoTM is a comprehensive database that collects data from echocardiograms performed across the United States. The Registry data provides valuable insights into the use and outcomes of echocardiography and helps clinicians make informed decisions and improve the quality of care at their institutions. For more information on the registry and enrollment, please visit ImageGuideEcho.org or contact Registry@ASEcho.org.

 

About ASE

The American Society of Echocardiography (ASE) is the Society for Cardiovascular Ultrasound Professionals™. ASE is the largest global organization for cardiovascular ultrasound imaging serving physicians, sonographers, nurses, veterinarians, and scientists and as such is the leader and advocate, setting practice standards and guidelines for the field. The Society is committed to advancing cardiovascular ultrasound to improve lives. For more information visit ASE’s website ASEcho.org or social media pages on Facebook, X (formerly Twitter), LinkedIn, or Instagram.

 

                                                                                ###

ASE Publishes Two New Guidelines in February 2024

 

FOR IMMEDIATE RELEASE

Contact: Angie Porter
919-297-7152
APorter@ASEcho.org

ASE Publishes Two Guidelines Recognizing Advances in Pediatric and Neonatal Echocardiography

(DURHAM, NC, February 5, 2024)—The American Society of Echocardiography (ASE) recently published two new guidelines offering updated recommendations on pediatric and neonatal echocardiography, replacing earlier guidelines published by the Society.

Guidelines for Performing a Comprehensive Pediatric Transthoracic Echocardiogram: Recommendations From the American Society of Echocardiography provides a comprehensive set of pediatric transthoracic echocardiography (TTE) guidelines to replace documents originally published by ASE in 2006 and 2010. The updated guideline establishes an organizational structure and a common language that can be utilized by any practice or institution providing echocardiographic services to children with suspected, congenital, or acquired heart disease.

“In the past decade, the care of children with heart disease has evolved due to improvements in scientific knowledge and technology. Echocardiography has played a major role in this evolution, due to its increasing ability to provide more accurate information related to cardiac anatomy, hemodynamics, and function,” says Leo Lopez, MD, FASE, chair of the guideline writing group. “The guideline helps organize the capabilities of echocardiography so that it can be used in a rational and logical way when caring for pediatric patients.”

One of the guideline’s writing group Co-Chairs, Carolyn Altman, MD, FASE, adds, “The document is designed to be an easy and convenient reference tool for busy clinicians and sonographers, and includes tables that succinctly summarize standard protocols and methods of quality improvement.”

The second guideline, titled Guidelines and Recommendations for Targeted Neonatal Echocardiography and Cardiac Point-of-Care Ultrasound in the Neonatal Intensive Care Unit: An Update from the American Society of Echocardiography, provides clarification on the scope of targeted neonatal echocardiography (TNE) versus cardiac point-of-care ultrasound (cPOCUS) to ensure that practitioners use these skills in accordance with approved indications. The guideline replaces the document originally published by ASE in 2011 and has been expanded to provide recommendations for cPOCUS, including:

  1. Guidance on the purpose and rationale for TNE and cPOCUS.
  2. Disease and/or clinical scenario-based indications for TNE.
  3. Training and competency-based evaluative requirements for TNE and cPOCUS.
  4. Components of quality assurance.

Chair of the guideline writing group Patrick McNamara, MD, FASE, says that he anticipates the updated guideline will enable more institutions to establish TNE or cPOCUS programs, generate new research, and continue to encourage collaborations between neonatologists and pediatric cardiologists.

“Close collaboration with pediatric echocardiography laboratories and the support of thought leaders in the field have resulted in the success of TNE and the establishment of neonatal hemodynamics programs. We must also acknowledge the pivotal role of Luc Mertens, MD, PhD, FASE, who chaired the original guideline writing group on this topic 13 years ago, for prompting the growth and evolution of the field of neonatal hemodynamics,” he adds.

Both guideline documents are published in the February 2024 issue of the Journal of the American Society of Echocardiography. All guidelines published by ASE are available at ASEcho.org/Guidelines.

About American Society of Echocardiography
The American Society of Echocardiography (ASE) is the Society for Cardiovascular Ultrasound Professionals™. ASE is the largest global organization for cardiovascular ultrasound imaging serving physicians, sonographers, nurses, veterinarians, and scientists and as such is the leader and advocate, setting practice standards and guidelines for the field. Both the pediatric and neonatal echocardiography specialized areas are represented in ASE’s Pediatric and Congenital Heart Disease Council and the Neonatal Hemodynamics TnECHO Specialty Interest Group. The Society is committed to advancing cardiovascular ultrasound to improve lives. For more information, visit the ASE website ASEcho.org or social media pages on Facebook, X, LinkedIn, or Instagram.

###

ASE Advocacy Update: CMS Interoperability and Prior Authorization Final Rule

ASE has been working to fight prior authorization on behalf of our members and joined several coalitions, including the Alliance of Specialty Medicine, to advance this issue.  There has been progress with Centers for Medicare & Medicaid Services (CMS) action today! The CMS Interoperability and Prior Authorization Final Rule has been finalized. The rule sets requirements for Medicare Advantage (MA) organizations, Medicaid and the Children’s Health Insurance Program (CHIP) fee-for-service (FFS) programs, Medicaid managed care plans, CHIP managed care entities, and issuers of Qualified Health Plans (QHPs) offered on the Federally-Facilitated Exchanges (FFEs), to improve the electronic exchange of health information and prior authorization processes for medical items and services.  Most of these changes will take effect in 2026.

Please see the CMS press release for more information, https://www.cms.gov/newsroom/press-releases/cms-finalizes-rule-expand-access-health-information-and-improve-prior-authorization-process

The fact sheet for this final rule is available here: https://www.cms.gov/newsroom/fact-sheets/cms-interoperability-and-prior-authorization-final-rule-cms-0057-f

ASE Publishes Updated Guideline for Evaluating PHVs

FOR IMMEDIATE RELEASE

Contact: Angie Porter
919-297-7152
APorter@ASEcho.org

ASE Publishes Updated Guideline for Evaluating Prosthetic Heart Valves

The guideline focuses on the use of echocardiography and multimodality imaging in evaluating patients with significant cardiac valvular disease

(DURHAM, NC, January 8, 2024)—A new guideline from the American Society of Echocardiography (ASE) aims to provide clinicians with a comprehensive resource for evaluating prosthetic heart valves (PHVs). Guidelines for the Evaluation of Prosthetic Valve Function with Cardiovascular Imaging: A Report from the American Society of Echocardiography Developed in Collaboration with the Society for Cardiovascular Magnetic Resonance and the Society of Cardiovascular Computed Tomography replaces the Society’s original guideline published in 2009.

While many principles and recommendations detailed in ASE’s original guideline on PHVs are still current and valid, the document was published prior to several important developments, including the function of percutaneous valves, the use of three-dimensional (3D) echocardiography, and the role of computed tomography (CT) and cardiac magnetic resonance (CMR) in the evaluation of PHVs.

“This new guideline on prosthetic valves was very much needed, as the field has changed so much since 2009, with the introduction of percutaneous valves and improvements in 3D echocardiography and multimodality imaging,” says Chair of the Guideline Writing Group Dr. William A. Zoghbi, Professor and Chairman of the Department of Cardiology at Houston Methodist Hospital in Texas. “It provides clinicians with a roadmap for evaluating PHVs, while aiming to improve patient care and outcomes in the field.”

Dr. Pei-Ni Jone, Co-Chair of the Guideline Writing Group and Director of the Echocardiography Laboratory at the Heart Center, as well as an Attending Physician in Cardiology at Ann & Robert H. Lurie Children’s Hospital of Chicago, adds, “The new guideline provides the clinician with much-needed information on how to evaluate PHVs with cardiac ultrasound, particularly with the added value of 3D echocardiography, and when to use further imaging with cardiac CT or CMR.”

Echocardiography is the first-line modality used to assess prosthetic valve function in patients with significant cardiac valvular disease. However, recent advances in CT and CMR have enhanced their roles in evaluating valvular heart disease. This new guideline offers guidance on which imaging modality can be most helpful for each respective valve and includes the newest valves available.

Additionally, the guideline consolidates critical information gleaned from imaging into tables and key points, while also offering a review of the echocardiographic techniques used and providing recommendations and general guidelines for evaluating prosthetic valve structure, function and regurgitation.

The new guideline is published in the January 2024 issue of the Journal of the American Society of Echocardiography. All guidelines published by ASE are available at ASEcho.org/Guidelines.

About American Society of Echocardiography
The American Society of Echocardiography (ASE) is the Society for Cardiovascular Ultrasound Professionals™. ASE is the largest global organization for cardiovascular ultrasound imaging serving physicians, sonographers, nurses, veterinarians, and scientists and as such is the leader and advocate, setting practice standards and guidelines for the field. The Society is committed to advancing cardiovascular ultrasound to improve lives. For more information, visit the ASE website ASEcho.org or social media pages on Facebook, X, LinkedIn, or Instagram.

 

###

New ASE Guideline Aims to Optimize Care for Pediatric Oncology Patients

FOR IMMEDIATE RELEASE

Contact: Angie Porter
919-297-7152
APorter@ASEcho.org

New Guideline Aims to Optimize Care for Pediatric Oncology Patients

The guideline focuses on the use of echocardiography and multimodality imaging in monitoring cardiac function in children with cancer

(DURHAM, NC, December 4, 2023)—A new guideline from the American Society of Echocardiography (ASE) offers recommendations to pediatric cardiologists and oncologists on the application of multimodality imaging in children undergoing cancer treatment.

Cardiovascular ultrasound has long been recognized as a valuable tool in assessing cardiac function and is the first-line imaging technique used to monitor cardiac function during and after cancer treatment in both adult and pediatric patients. However, as the field of pediatric cardio-oncology continues to evolve, children with cancer may also benefit from the addition of other noninvasive imaging techniques.

The newly released guideline, titled “Multimodality Imaging for Cardiac Surveillance of Cancer Treatment in Children: Recommendations From the American Society of Echocardiography,” provides detailed guidance on how to perform echocardiographic exams, which parameters to use in clinical decision making, and the circumstances under which additional imaging modalities, such as magnetic resonance imaging (MRI) and computed tomography (CT), should be considered.

“Cardiovascular complications developing during and after cancer treatment remain a significant challenge and continue to compromise the long-term health of this growing patient cohort,” says Luc Mertens, MD, PhD, FASE, chair of the guideline writing group. “The primary goal of cardiac monitoring is to identify early signs of potentially reversible heart disease and to minimize the risk of progression from asymptomatic to clinically overt heart disease.”

The document also stresses that therapeutic decisions should be based on multidisciplinary discussions among cardiologists, oncology teams, and the patient and their family.

“This guideline highlights the knowledge gaps in the current practice of cardiac monitoring and cautions making therapeutic decisions on cancer treatment for pediatric patients solely on cardiac imaging data,” says Gautam Singh, MD, FASE, co-chair of the writing group. “By standardizing the use of echocardiography and providing evidence-based recommendations, this guideline can help improve long-term cardiac outcomes of pediatric cancer patients.”

This document is published in the December 2023 issue of the Journal of the American Society of Echocardiography. All guidelines published by ASE are available at ASEcho.org/Guidelines.

About American Society of Echocardiography
The American Society of Echocardiography (ASE) is the Society for Cardiovascular Ultrasound Professionals™. ASE is the largest global organization for cardiovascular ultrasound imaging serving physicians, sonographers, nurses, veterinarians, and scientists and as such is the leader and advocate, setting practice standards and guidelines for the field. The Society is committed to advancing cardiovascular ultrasound to improve lives. For more information, visit the ASE website ASEcho.org or social media pages on Facebook, Twitter, LinkedIn, or Instagram.

###

 

GivingTuesday 2023

 

The ASE Foundation is Accepting
GivingTuesday Donations November 26-December 2

Fundraising Goal: $35,000

The ASE Foundation is proud to participate in the global generosity movement known as GivingTuesday. Your donation ensures that we continue to foster the next generation of cardiovascular ultrasound professionals, award research grants to investigators, bring cardiac care to areas in need, among other charitable projects in 2024.

The Foundation celebrates the generosity of our donors every day. After all, YOU are what makes us successful! Your donations provide support for initiatives, such as student scholarships, scientific research, and guideline dissemination, that are not supported by ASE membership dues.

Click here to donate today. No matter where your heart lies, the Foundation can support your passion and you can take pride in knowing that 100% of your donation goes back out into the field. Donations towards our $35,000 fundraising goal will be accepted through December 2. Together we can continue to make a world of difference!

Apply for an ASE/ASEF Leadership Position

Now is your chance to become a leader in ASE and the ASE Foundation! If you are an active member and meet the criteria outlined for the position, ask a friend or colleague who is also an ASE member to submit a nomination on your behalf. All available positions are open to any ASE member, regardless of their specialty, and we are looking for a diverse pool of nominees.

November 30, 2023, is the deadline for candidates to submit all materials required for available positions on the ASE Foundation Board of Directors and Council Steering Committees.

December 7, 2023, is the deadline for candidates to submit all materials required for available positions on the ASE Board of Directors and ASE Executive Committee. Changes were recently made to the criteria for Treasurer, Secretary, and Council Representative. See if you qualify.

Learn More & Apply!

Download the New Echo for Cardiac Amyloidosis Poster

ASE offers a variety of echocardiography and amyloidosis resources, and we are happy to announce a new, free poster available now on our website! Download the Echo for Cardiac Amyloidosis poster that was produced by ASE in collaboration with Pfizer. This piece was created from an article “Practical Points for Echocardiography in Cardiac Amyloidosis” that was published in the Journal of the American Society of Echocardiography. This new poster focuses on the common echocardiographic imaging findings of cardiac amyloidosis (CA), and highlights red flags that should raise suspicion for the diagnosis. It offers practical tips for image acquisition and interpretation and outlines recommendations for standard reporting of an echocardiogram in a patient with CA.